Friday, May 9, 2025

Marc ZERBOLA CHALLANDE

224 POSTS
Marc has been involved in the Stock Market Media Industry for the last +5 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website.

Exclusive articles:

Trump’s Tariffs Spark Stock Market Turmoil: A Mid-2025 Meltdown

Wall Street just had its worst week since 2020 — and you can thank tariffs for that. President Donald Trump's "Liberation Day" tariffs, unveiled in...

Trump Imposes 25% Tariffs on Imported Autos, Prompting Global Backlash

President Donald Trump has announced a 25% tariff on imported automobiles and parts, effective April 3, 2025—a move expected to generate $100 billion annually...

Mangoceuticals, Inc. (NASDAQ: MGRX) Secures Exclusive Rights to Diabetinol®, Entering $33.6 Billion Diabetes Market

Mangoceuticals, Inc. (NASDAQ: MGRX), operating as MangoRx, is a Dallas-based telemedicine company specializing in men's health and wellness. The company offers treatments for conditions...

Trump Threatens to Impose Tariffs on Whoever Buys Oil from Venezuela

In a bold and provocative move, former U.S. President Donald Trump has issued a stark warning: any country or company that purchases oil from...

MangoRx (NASDAQ: MGRX) Is Empowering Health and Wellness Through Innovation

MangoRx (NASDAQ: MGRX) is a health and wellness company dedicated to empowering individuals with effective solutions in key areas of personal well-being. The company...

Breaking

Trump’s New Tariffs Send Shockwaves Across Key Sectors

President Donald Trump is making headlines again this week...

Buffett Passes the Torch: What’s Next for Berkshire?

Shares of Berkshire Hathaway (NYSE: BRK.A, BRK.B) took a...

NurExone Biologic (NRX): A Biotech Stock Turning Heads in 2025

NurExone Biologic Inc. (TSXV: NRX, OTCQB: NRXBF), an Israeli-based...

Mangoceuticals (NASDAQ: MGRX): A Small-Cap Contender with Major Upside in Men’s Health and Wellness

Summary Mangoceuticals, Inc. (NASDAQ: MGRX) is transforming from a niche...
spot_img